Progressis^® is Ceva’s inactivated PRRSV vaccine. It targets reproductive animals, especially to boost immunity originally obtained by vaccination with an MLV vaccine or by field infection. Its obvious advantage over MLV vaccines is it safety profile; because of its inactivated nature it will not replicate in the vaccinated animal, mutate or spread.

COMPOSITION

Each 2-ml dose of vaccine contains:

Active substance: Inactivated Porcine Reproductive and Respiratory Syndrome (PRRS) virus, P120 strain, 2.5 log 10 IF* units. *IF units: ImmunoFluorescence antibody titre obtained after 2 injections in pigs under specific laboratory conditions.

Adjuvant: O/W oily excipient q.s. 1 dose of 2 ml.

INDICATION

Reduction of the reproductive disorders caused by Porcine Reproductive and Respiratory Syndrome virus in a contaminated environment: vaccination reduces the number of early farrowings and the number of stillbirths.

In PRRS infected herds, viral infection is heterogeneous and varies over time. In such context, the implementation of a vaccination program is a tool to improve the reproductive parameters and may contribute to the disease control in conjunction with sanitary measures.

HOW TO USE PROGRESSIS?

One dose of 2 ml is administered by deep intramuscular route, in the neck muscles behind the ear, according to the following vaccination scheme:

Primary vaccination:
Gilts: 2 injections 3-4 weeks apart, at least 3 weeks before mating.
Sows: 2 injections 3-4 weeks apart (vaccination of all the sows of the herd within a short period is recommended).

Revaccination: One injection at 60-70 days of each gestation, as of the first gestation following the primary vaccination.

WITHDRAWAL PERIOD

Zero days.